03 March 2020
More than 20 vaccines are being developed across the world, WHO Director-General Tedros Adhanom Ghebreyesus said at a briefing on February 28.
“More than 20 vaccines are in development globally, and several therapeutics are in clinical trials,” he said adding that the first results were expected “in a few weeks.”
The head of the World Health Organization (WHO) is concerned about the “risk of spread and the risk of impact of COVID-19” assessing it as “very high at a global level.” The WHO earlier assessed this level as “high”.
“We do not see evidence as yet that the virus is spreading freely in communities,” he said adding that “we still have a chance of containing this coronavirus.”
Apart from China, 52 other countries have reported confirmed coronavirus cases. According to the latest reports, China has confirmed over 78,800 cases of patients infected with the novel coronavirus. The virus’ death toll has hit 2,788, yet more than 36,100 patients have recovered from the disease.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
InFigures European Pharma Hotspots 2024
05 November 2024
Federal project to combat hepatitis C will be launched in 2025
05 November 2024
Federal project to combat hepatitis C will be launched in 2025
01 November 2024
Domestic drugs now make up 60% of Russian pharmacies
01 November 2024